25th Feb 2016 14:45
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
| 1 | Issuer | Oxford BioMedica PLC | 
| 2 | Reason for notification | Notification relates to DTR 3.1.2R | 
| 3 | Name of PDMR | Martin Diggle | 
| 4 | Connected person | Notification relates to following connected persons: Vulpes Life Sciences Fund | 
| 5 | Notification in respect of | Notification in respect of holdings of persons in 4 above | 
| 6 | Description of shares | Oxford BioMedica PLC ordinary shares of 1p each | 
| 7 | Name of registered shareholders and number of shares | Vulpes Life Sciences Fund - 451,284,439 shares | 
| 8 | Nature of transaction | Acquisition | 
| 9 | Number of shares acquired 
 | Vulpes Life Sciences Fund - 46,693 shares 
 | 
| 10 | Percentage of issued class acquired | Vulpes Life Sciences Fund - 0.001% 
 | 
| 11 | Shares disposed | N/A 
 | 
| 12 | Percentage of issued class disposed | N/A 
 | 
| 13/14 | Price per share of transactions, and date | Vulpes Life Sciences Fund 46,693 shares @ £0.0635 , 24 Feb 2016 
 | 
| 15 | Total holding following notification and total percentage holding following notification | Vulpes Life Sciences Fund - 475,140,655 shares 17.57% | 
| 16 | Date issuer informed | 25 Feb 2016 | 
| 23 | Any additional information | None | 
| 24 | Contact name and telephone number | T. Watts, Chief Financial Officer Oxford BioMedica +44 (0)1865 783000 | 
Related Shares:
Oxford Biomedica